INVESTORS
Zafgen (Nasdaq:ZFGN) is a biopharmaceutical company that has leveraged its proprietary MetAP2 biology platform to pioneer the study of MetAP2 inhibitors in both common and rare metabolic disorders.
Day High:
Day Low:
Volume:
Day Low:
Volume:
Copyright West LLC. Minimum 15 minutes delayed.